Zeta Cytokeratin 18 Antibody. Zeta’s mouse monoclonal antibody recognizes Cytokeratin 18, belongs to the type A (acidic) subfamily of low molecular weight keratins and serum tumor marker for breast cancer. The Cytokeratin 18 antibody reacts with a wide variety of simple epithelia. The Cytokeratin 18 antibody does not react with stratified squamous epithelia. The Cytokeratin 18 antibody reacts with epithelial tumors of the gastrointestinal tract, lung, breast, pancreas, ovary, and thyroid. Cytokeratin 18, which belongs to the type A (acidic) subfamily of low molecular weight keratins, exists in combination with Cytokeratin 8. Tissues from gastrointestinal tract are positive for both Cytokeratin 8 and 18 but do not contain Cytokeratin 14. Tissues from gastrointestinal tract, respiratory tract and urogenital tract, as well as endocrine and exocrine tissues and mesothelial cells are positive for Cytokeratin 18.
Zeta Corporation is a leader in recombinant monoclonal IVD antibodies for immunohistochemistry (IHC) offering 400+ tumor and tissue specific relevant products developed by a pathologist for pathologists. Visit Precision Recombinant Antibodies – IVD Antibodies – About Zeta Corporation (zeta-corp.com) to learn more about Zeta Corporation.